{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:11:04Z","timestamp":1779408664211,"version":"3.53.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100003249","name":"Pennington Family Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100003249","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Humanized mouse models are essential for evaluating the engraftment capacity and genetic integrity of gene-modified hematopoietic stem and progenitor cells (HSPCs). Here, we compared two widely used xenotransplantation platforms, NSG and NBSGW mice, in the context of lentiviral vector (LVV) transduction and CRISPR\/Cas9-mediated gene correction. HSPCs harboring high LVV copy numbers exhibited engraftment deficits in NSG mice that were not observed in NBSGW mice. This discrepancy highlights the potential for the NBSGW model to mask safety liabilities of LVV-modified products due to its higher overall levels of human chimerism. In contrast, CRISPR\/Cas9 editing with a single-stranded oligodeoxynucleotide donor yielded comparable correction rates in both models, even across decreasing input cell doses, demonstrating that long-term repopulating hematopoietic stem cells (HSCs) retain equivalent engraftment capacity in each strain. Single-cell RNA-sequencing revealed distinct progenitor populations that were markedly under-represented in the NSG model but preserved in NBSGW recipients, emphasizing the greater capacity of NBSGW mice to better support multilineage human hematopoiesis. Together, these findings establish that both NSG and NBSGW mice are suitable for assessing long-term engraftment and gene modification outcomes in human HSPCs. However, the significantly higher percentage of human cell chimerism in the NBSGW model may obscure cell populations with engraftment deficits. Careful selection of in vivo models is therefore critical for rigorous preclinical evaluation of gene therapy products prior to clinical translation.<\/jats:p>","DOI":"10.1186\/s13287-026-05010-8","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T11:22:44Z","timestamp":1776252164000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative analysis of NSG and NBSGW mice for preclinical evaluation of gene-modified human hematopoietic stem and progenitor cells"],"prefix":"10.1186","volume":"17","author":[{"given":"Caroline Y.","family":"Kuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Campo-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacia K.","family":"Wyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Espinoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno J.","family":"de Andrade Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorel","family":"Fitz-Gibbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-hong","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Bonner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zulema","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"issue":"2","key":"5010_CR1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1182\/blood-2010-02-271841","volume":"116","author":"SP McDermott","year":"2010","unstructured":"McDermott SP, Eppert K, Lechman ER, Doedens M, Dick JE. Comparison of human cord blood engraftment between immunocompromised mouse strains. Blood. 2010;116(2):193\u2013200.","journal-title":"Blood"},{"issue":"1","key":"5010_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1634\/stemcells.2008-0583","volume":"27","author":"J Hayakawa","year":"2009","unstructured":"Hayakawa J, Hsieh MM, Uchida N, Phang O, Tisdale JF. Busulfan produces efficient human cell engraftment in NOD\/LtSz- Scid IL2R\u03b3 null mice. Stem Cells. 2009;27(1):175\u201382.","journal-title":"Stem Cells"},{"issue":"9","key":"5010_CR3","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.exphem.2007.05.009","volume":"35","author":"MM Hsieh","year":"2007","unstructured":"Hsieh MM, Langemeijer S, Wynter A, Phang OA, Kang EM, Tisdale JF. Low-dose parenteral busulfan provides an extended window for the infusion of hematopoietic stem cells in murine hosts. Exp Hematol. 2007;35(9):1415\u201320.","journal-title":"Exp Hematol"},{"issue":"2","key":"5010_CR4","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/0012-1606(79)90130-1","volume":"72","author":"TW Poole","year":"1979","unstructured":"Poole TW, Silvers WK. Capacity of adult steel (S\/\/Ud) and dominant spotting (W\/W) mouse skin to support melanogenesis\u2019. Develop Biol. 1979;72(2):398\u2013400.","journal-title":"Develop Biol"},{"issue":"2","key":"5010_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.stemcr.2014.12.005","volume":"4","author":"BE McIntosh","year":"2015","unstructured":"McIntosh BE, Brown ME, Duffin BM, Maufort JP, Vereide DT, Slukvin II, et al. Nonirradiated NOD,B6.SCID Il2r\u03b3-\/- kitW41\/W41 (NBSGW) mice support multilineage engraftment of human hematopoietic cells. Stem Cell Rep. 2015;4(2):171\u201380.","journal-title":"Stem Cell Rep"},{"issue":"9","key":"5010_CR6","doi-asserted-by":"publisher","first-page":"E513","DOI":"10.1002\/ajh.24805","volume":"92","author":"C Fiorini","year":"2017","unstructured":"Fiorini C, Abdulhay NJ, McFarland SK, Munschauer M, Ulirsch JC, Chiarle R, et al. Developmentally-faithful and effective human erythropoiesis in immunodeficient and Kit mutant mice. Am J Hematol. 2017;92(9):E513\u20139.","journal-title":"Am J Hematol"},{"issue":"4","key":"5010_CR7","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1182\/bloodadvances.2023011371","volume":"8","author":"S Choo","year":"2024","unstructured":"Choo S, Wolf CB, Mack HM, Egan MJ, Kiem HP, Radtke S. Choosing the right mouse model: comparison of humanized NSG and NBSGW mice for in vivo HSC gene therapy. Blood Adv. 2024;8(4):916\u201326.","journal-title":"Blood Adv"},{"key":"5010_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.exphem.2016.12.012","volume":"48","author":"PH Miller","year":"2017","unstructured":"Miller PH, Rabu G, MacAldaz M, Knapp DJHF, Cheung AMS, Dhillon K, et al. Analysis of parameters that affect human hematopoietic cell outputs in mutant c-kit-immunodeficient mice. Exp Hematol. 2017;48:41\u20139.","journal-title":"Exp Hematol"},{"key":"5010_CR9","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.omtm.2019.10.017","volume":"15","author":"A Leonard","year":"2019","unstructured":"Leonard A, Yapundich M, Nassehi T, Gamer J, Drysdale CM, Haro-Mora JJ, et al. Low-Dose Busulfan Reduces Human CD34\u2009+\u2009Cell Doses Required for Engraftment in c-kit Mutant Immunodeficient Mice. Mol Ther Methods Clin Dev. 2019;15:430\u20137.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"5010_CR10","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf9336","author":"MA Dewitt","year":"2016","unstructured":"Dewitt MA, Magis W, Bray NL, Wang T, Berman JR, Urbinati F, et al. Selection-free genome editing of the sickle mutation in human adult hematopoietic stem\/progenitor cells. Sci Transl Med. 2016. https:\/\/doi.org\/10.1126\/scitranslmed.aaf9336.","journal-title":"Sci Transl Med"},{"issue":"14","key":"5010_CR11","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1056\/NEJMoa2405541","volume":"391","author":"CN Duncan","year":"2024","unstructured":"Duncan CN, Bledsoe JR, Grzywacz B, Beckman A, Bonner M, Eichler FS, et al. Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy. N Engl J Med. 2024;391(14):1287\u2013301.","journal-title":"N Engl J Med"},{"issue":"8","key":"5010_CR12","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.ymthe.2019.05.014","volume":"27","author":"Z Romero","year":"2019","unstructured":"Romero Z, Lomova A, Said S, Miggelbrink A, Kuo CY, Campo-Fernandez B, et al. Editing the Sickle Cell Disease Mutation in Human Hematopoietic Stem Cells: Comparison of Endonucleases and Homologous Donor Templates. Mol Ther. 2019;27(8):1389\u2013406.","journal-title":"Mol Ther"},{"issue":"4","key":"5010_CR13","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.stem.2019.02.019","volume":"24","author":"G Schiroli","year":"2019","unstructured":"Schiroli G, Conti A, Ferrari S, della Volpe L, Jacob A, Albano L, et al. Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response. Cell Stem Cell. 2019;24(4):551\u2013e5658.","journal-title":"Cell Stem Cell"},{"issue":"7629","key":"5010_CR14","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature20134","volume":"539","author":"DP Dever","year":"2016","unstructured":"Dever DP, Bak RO, Reinisch A, Camarena J, Washington G, Nicolas CE, et al. CRISPR\/Cas9 \u03b2-globin gene targeting in human haematopoietic stem cells. Nature. 2016;539(7629):384\u20139.","journal-title":"Nature"},{"issue":"9","key":"5010_CR15","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1016\/j.celrep.2018.04.103","volume":"23","author":"CY Kuo","year":"2018","unstructured":"Kuo CY, Long JD, Campo-Fernandez B, de Oliveira S, Cooper AR, Romero Z, et al. Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM Syndrome. Cell Rep. 2018;23(9):2606\u201316.","journal-title":"Cell Rep"},{"issue":"18","key":"5010_CR16","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1056\/NEJMoa2309676","volume":"390","author":"H Frangoul","year":"2024","unstructured":"Frangoul H, Locatelli F, Sharma A, Bhatia M, Mapara M, Molinari L, et al. Exagamglogene Autotemcel for Severe Sickle Cell Disease. N Engl J Med. 2024;390(18):1649\u201362.","journal-title":"N Engl J Med"},{"key":"5010_CR17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-12-615948","author":"MD Hoban","year":"2015","unstructured":"Hoban MD, Cost GJ, Mendel MC, Romero Z, Kaufman ML, Joglekar AV, et al. Correction of the sickle cell disease mutation in human hematopoietic stem\/progenitor cells Key Points. Blood J American Soc Hematol. 2015. https:\/\/doi.org\/10.1182\/blood-2014-12-615948.","journal-title":"Blood J American Soc Hematol"},{"issue":"2","key":"5010_CR18","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/stem.2935","volume":"37","author":"A Lomova","year":"2019","unstructured":"Lomova A, Clark DN, Campo-Fernandez B, Flores-Bjurstr\u00f6m C, Kaufman ML, Fitz-Gibbon S, et al. Improving Gene Editing Outcomes in Human Hematopoietic Stem and Progenitor Cells by Temporal Control of DNA Repair. Stem Cells. 2019;37(2):284\u201394.","journal-title":"Stem Cells"},{"issue":"7504","key":"5010_CR19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature13420","volume":"510","author":"P Genovese","year":"2014","unstructured":"Genovese P, Schiroli G, Escobar G, Di Tomaso T, Firrito C, Calabria A, et al. Targeted genome editing in human repopulating haematopoietic stem cells. Nature. 2014;510(7504):235\u201340.","journal-title":"Nature"},{"key":"5010_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104374","author":"W Magis","year":"2022","unstructured":"Magis W, DeWitt MA, Wyman SK, Vu JT, Heo SJ, Shao SJ, et al. High-level correction of the sickle mutation is amplified in vivo during erythroid differentiation. iScience. 2022. https:\/\/doi.org\/10.1016\/j.isci.2022.104374.","journal-title":"iScience"},{"key":"5010_CR21","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.stem.2012.01.006","volume":"10","author":"S Doulatov","year":"2012","unstructured":"Doulatov S, Notta F, Laurenti E, Dick JE. Hematopoiesis: a human perspective. Cell Stem Cell. 2012;10:120\u201336.","journal-title":"Cell Stem Cell"},{"key":"5010_CR22","volume-title":"From haematopoietic stem cells to complex differentiation landscapes","author":"E Laurenti","year":"2018","unstructured":"Laurenti E, G\u00f6ttgens B. From haematopoietic stem cells to complex differentiation landscapes, vol. 553. London: Nature Publishing Group; 2018."},{"key":"5010_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10291-0","author":"D Pellin","year":"2019","unstructured":"Pellin D, Loperfido M, Baricordi C, Wolock SL, Montepeloso A, Weinberg OK, et al. A comprehensive single cell transcriptional landscape of human hematopoietic progenitors. Nat Commun. 2019. https:\/\/doi.org\/10.1038\/s41467-019-10291-0.","journal-title":"Nat Commun"},{"key":"5010_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.exphem.2018.09.004","volume":"68","author":"SB Hay","year":"2018","unstructured":"Hay SB, Ferchen K, Chetal K, Grimes HL, Salomonis N. The human cell atlas bone marrow single-cell interactive web portal. Exp Hematol. 2018;68:51\u201361.","journal-title":"Exp Hematol"},{"issue":"4","key":"5010_CR25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.stemcr.2016.08.005","volume":"7","author":"S Rahmig","year":"2016","unstructured":"Rahmig S, Kronstein-Wiedemann R, Fohgrub J, Kronstein N, Nevmerzhitskaya A, Bornh\u00e4user M, et al. Improved Human Erythropoiesis and Platelet Formation in Humanized NSGW41 Mice. Stem Cell Rep. 2016;7(4):591\u2013601.","journal-title":"Stem Cell Rep"},{"key":"5010_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/srep02189","author":"AC Bester","year":"2013","unstructured":"Bester AC, Kafri M, Maoz K, Kerem B. Infection with retroviral vectors leads to perturbed DNA replication increasing vector integrations into fragile sites. Sci Rep. 2013. https:\/\/doi.org\/10.1038\/srep02189.","journal-title":"Sci Rep"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-05010-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05010-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05010-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T23:16:16Z","timestamp":1779405376000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-026-05010-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5010"],"URL":"https:\/\/doi.org\/10.1186\/s13287-026-05010-8","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"1 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All work with mice was done under protocols approved by a local institutional animal care and use committee (IACUC; bluebird bio (now known as Genetix Biotherapeutics). Alternatively, all work with mice was done under protocols approved by the UCLA Institutional Animal Care and Use Committee. Mouse work was performed according to the animal research committee (ARC) protocol number 2008\u2009\u2212\u2009167. The title of the approved project at UCLA was \u201cAnalysis of gene transfer and expression in human hematopoietic stem\/progenitor cells by growth in immune deficient mice (Mice)\u201d under the Protocol ARC-2008-167 (last Approval Period from 03\/11\/2025 through 12\/04\/2026). The title of the approved project at bluebird bio (now known as Genetix Biotherapeutics) was \u201cMurine Stem Cell Engraftment Models\u201d under the IACUC protocol 00214 (originally approved on September 1\u2009st, 2017).\u00a0Mice were purchased from The Jackson Laboratory, Bar Harbor, ME.\u00a0G-CSF (and Plerixafor) mobilized peripheral blood leukopaks were purchased from CGT Global (Folsom, CA) and Charles Rivers (Van Nuys, CA) from anonymous donors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"196"}}